Entrada Therapeutics Inc. – Transcripts

NASDAQ: TRDA
Share price (10/7/26): $5.61
Market cap (10/7/26): $218 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Other Revised 06/08/26 Entrada Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08:00 AM 06/08/26

Earnings Revised 05/11/26 Entrada Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026 05/07/26

Other Revised 01/15/26 Entrada Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 03:45 PM 01/14/26

CY 2025

Other Revised 09/26/25 Entrada Therapeutics, Inc. - Special Call 09/25/25

Other Revised 06/09/25 Entrada Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08:00 AM 06/09/25

Other Revised 01/15/25 Entrada Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 11:15 AM 01/15/25

CY 2024

Other Revised 06/10/24 Entrada Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 04:00 PM 06/10/24

CY 2023

Other Revised 06/14/23 Entrada Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 10:40 AM 06/14/23

CY 2022

Other Revised 06/14/22 Entrada Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-14-2022 02:40 PM 06/14/22